Bigelow LB - Search Results

1

Neuroleptics decrease blinking in schizophrenic subjects.

Karson C, Freed WJ, Kleinman JE, Bigelow LB, Wyatt RJ. Karson C, et al. Among authors: bigelow lb. Biol Psychiatry. 1981 Jul;16(7):679-82. Biol Psychiatry. 1981. PMID: 6115684 No abstract available.

2

P-chlorophenylalanine trials in schizophrenic patients.

DeLisi LE, Freed WJ, Gillin JC, Kleinman JE, Bigelow LB, Wyatt RJ. DeLisi LE, et al. Among authors: bigelow lb. Biol Psychiatry. 1982 Apr;17(4):471-7. Biol Psychiatry. 1982. PMID: 6211196 No abstract available.

3

An effect of neuroleptic medication on plasma dopamine-beta-hydroxylase activity.

DeLisi LE, Phelps BH, Wise CD, Apostoles PS, Bigelow L, Wyatt RJ. DeLisi LE, et al. Biol Psychiatry. 1981 Sep;16(9):873-8. Biol Psychiatry. 1981. PMID: 6117334 No abstract available.

4

Quantitative autoradiography of dopamine-D1 receptors, D2 receptors, and dopamine uptake sites in postmortem striatal specimens from schizophrenic patients.

Knable MB, Hyde TM, Herman MM, Carter JM, Bigelow L, Kleinman JE. Knable MB, et al. Biol Psychiatry. 1994 Dec 15;36(12):827-35. doi: 10.1016/0006-3223(94)90593-2. Biol Psychiatry. 1994. PMID: 7893846

5

Clinical effects of L-5-hydroxytryptophan administration in chronic schizophrenic patients.

Bigelow LB, Walls P, Gillin JC, Wyatt RJ. Bigelow LB, et al. Biol Psychiatry. 1979 Feb;14(1):53-67. Biol Psychiatry. 1979. PMID: 369623 Clinical Trial.

6

Tardive dyskinesia: neuropsychological, computerized tomographic, and psychiatric symptom findings.

Gold JM, Egan MF, Kirch DG, Goldberg TE, Daniel DG, Bigelow LB, Wyatt RJ. Gold JM, et al. Among authors: bigelow lb. Biol Psychiatry. 1991 Sep 15;30(6):587-99. doi: 10.1016/0006-3223(91)90028-k. Biol Psychiatry. 1991. PMID: 1681948

7

Polydipsia and chronic hyponatremia in schizophrenic inpatients.

Kirch DG, Bigelow LB, Weinberger DR, Lawson WB, Wyatt RJ. Kirch DG, et al. Among authors: bigelow lb. J Clin Psychiatry. 1985 May;46(5):179-81. J Clin Psychiatry. 1985. PMID: 2859275

8

Violent behavior in schizophrenic inpatients.

Karson C, Bigelow LB. Karson C, et al. Among authors: bigelow lb. J Nerv Ment Dis. 1987 Mar;175(3):161-4. doi: 10.1097/00005053-198703000-00006. J Nerv Ment Dis. 1987. PMID: 2880927

9

Effect of valproic acid on behavior and plasma amino acid concentrations in chronic schizophrenic patients.

Ko GN, Korpi ER, Freed WJ, Zalcman SJ, Bigelow LB. Ko GN, et al. Among authors: bigelow lb. Biol Psychiatry. 1985 Feb;20(2):209-15. doi: 10.1016/0006-3223(85)90085-x. Biol Psychiatry. 1985. PMID: 3918589 Clinical Trial. No abstract available.

10

Cerebral ventricular enlargement in chronic schizophrenia. An association with poor response to treatment.

Weinberger DR, Bigelow LB, Kleinman JE, Klein ST, Rosenblatt JE, Wyatt RJ. Weinberger DR, et al. Among authors: bigelow lb. Arch Gen Psychiatry. 1980 Jan;37(1):11-3. doi: 10.1001/archpsyc.1980.01780140013001. Arch Gen Psychiatry. 1980. PMID: 6101534

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

110 results

Search Page

Filters